Médecins Sans Frontières

South Africa takes landmark step for access to medicines

MSF applauds effort to ‘take off patent blindfold’ and change patent laws to increase access to affordable medicines

Read More →

MSF welcomes Members of the European Parliament response to the US pharmaceutical pressure to stop EU action on high drug prices

6 March 2018 The Pharmaceutical Research and Manufacturers of America (PhRMA) and the Biotechnology Innovation Organization (BIO), two US pharmaceutical lobby groups, have requested the US Trade Representative (USTR) to place the European Union (EU) on its 2018 Special 301 Report. This highly controversial Report by the USTR is an annual unilateral review of the enforcement of intellectual property rights (IPR) in other countries, and used as means to pressure countries to comply with the US demands for tougher IP rules that would eventually benefit the US pharmaceutical industry.

Read More →

Promising MSF research highlights immense benefits, need for expanded use of DR-TB drug combination

NEW YORK, FEBRUARY 14, 2018—New research published today in The Lancet Infectious Diseases journal by the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) provides strong evidence that a combination of two new drugs for tuberculosis (TB)—the world’s leading infectious disease killer—could be used to treat drug-resistant (DR-TB) forms of the disease. These findings encourage the wider use of these medicines in combination for DR-TB patients worldwide.

Read More →

GeneXpert Omni factsheet

Médecins Sans Frontières released a factsheet about GeneXpert Omni expressing concerns on the suitability of the tool for remote settings within low-to-middle income countries. GeneXpert Omni is a single-module point-of-care device produced by Cepheid.

Read More →

TB: Governments given deadline to increase testing and treatment

Petition signed by more than 30,000 people from 120 countries presented to head of WHO and Ministers of Health.

Read More →

Russian Federation: TB treatments yield promising results in the Chechen Republic

The first new drugs to be developed in 50 years were the last chance for some people with extensively drug-resistant tuberculosis (XDR-TB) in the Chechen Republic of the Russian Federation. In 2015, MSF’s Maria Borshova spoke to patients who had just started their new two-year-long treatments. She recently met them again.

Read More →

People still being denied improved treatment for multidrug-resistant TB

Médecins Sans Frontières urges governments to step up the use of newer TB drugs.

Read More →

Vacancy: TB Advocacy Officer, MSF Access Campaign

Médecins Sans Frontières (MSF) Access Campaign is opening the position of TB Advocacy Officer.

Read More →

MSF sounds alarm over high numbers of people dying with AIDS in sub-Saharan Africa

Global attention needed to prevent and treat AIDS in antiretroviral era, with 50% of hospital admissions in MSF hospitals already on treatment and showing clinical signs of failure; TB and cryptococcal meningitis remain HIV patients’ primary comorbidities.

Read More →

MSF urges G20 to take action on health issues

Ahead of the G20 Summit in Hamburg, where global health is on the agenda for the first time, the international medical humanitarian organisation Médecins Sans Frontières (MSF) called on G20 leaders to follow through on the declaration made by their health ministers in late May.

Read More →

Page 1 of 5 · Total posts: 10

1 2 Last→